Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Colorcon
Mallinckrodt
Merck
Chinese Patent Office
Medtronic
Express Scripts
Baxter
Boehringer Ingelheim
Chubb

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019829

« Back to Dashboard

NDA 019829 describes CERETEC, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from two suppliers. Additional details are available on the CERETEC profile page.

The generic ingredient in CERETEC is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.

Summary for 019829

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Pharmacology for NDA: 019829

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 019829

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829 NDA Medi-Physics Inc. dba GE Healthcare. 17156-022 17156-022-05 5 VIAL in 1 TRAY (17156-022-05) > 5 mL in 1 VIAL
CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829 NDA Medi-Physics Inc. 17156-023 17156-023-05 1 KIT in 1 CARTON (17156-023-05) * 5 VIAL in 1 TRAY > 1 mL in 1 VIAL * 5 VIAL in 1 TRAY > 4.5 mL in 1 VIAL * 5 VIAL in 1 TRAY (17156-022-05) > 5 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Dec 30, 1988TE:RLD:Yes

Expired Orange Book Patents for NDA: 019829

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareCERETECtechnetium tc-99m exametazime kitINJECTABLE;INJECTION019829-001Dec 30, 1988► Subscribe► Subscribe
Ge HealthcareCERETECtechnetium tc-99m exametazime kitINJECTABLE;INJECTION019829-001Dec 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Farmers Insurance
Teva
Federal Trade Commission
UBS
Novartis
Healthtrust
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot